Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Delayed Presentation of DPD Deficiency in Colorectal Cancer.

Law L, Rogers J, Eng C.

J Adv Pract Oncol. 2014 May;5(3):205-10. Review.

2.

Thirteen years experience with selective screening for disorders in purine and pyrimidine metabolism.

Castro M, Carrillo R, García F, Sanz P, Ferrer I, Ruiz-Sala P, Vega AI, Ruíz Desviat L, Pérez B, Pérez-Cerdá C, Merinero B, Ugarte M.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):233-40. doi: 10.1080/15257770.2013.854381. Review.

PMID:
24940674
3.

Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature.

Mokrim M, Aftimos PG, Errihani H, Piccart-Gebhart M.

BMJ Case Rep. 2014 Apr 19;2014. pii: bcr2014203647. doi: 10.1136/bcr-2014-203647. Review.

PMID:
24748142
4.

Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice.

Papanastasopoulos P, Stebbing J.

Anticancer Res. 2014 Apr;34(4):1531-5. Review.

PMID:
24692679
5.

[A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer].

Toshima T, Kodera M, Yamashita Y, Oishi M, Seshimo K, Yamamura M, Kato H, Ikeda H, Mizuno K.

Gan To Kagaku Ryoho. 2013 Nov;40(11):1549-52. Review. Japanese.

PMID:
24231713
6.

Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency.

van Staveren MC, Guchelaar HJ, van Kuilenburg AB, Gelderblom H, Maring JG.

Pharmacogenomics J. 2013 Oct;13(5):389-95. doi: 10.1038/tpj.2013.25. Epub 2013 Jul 16. Review. Erratum in: Pharmacogenomics J. 2014 Aug;14(4):400.

PMID:
23856855
7.

Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients.

van Kuilenburg AB, Maring JG.

Pharmacogenomics. 2013 May;14(7):799-811. doi: 10.2217/pgs.13.54. Review.

PMID:
23651027
8.

Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.

Chung C, Christianson M.

J Oncol Pharm Pract. 2014 Feb;20(1):11-28. doi: 10.1177/1078155212474047. Epub 2013 Mar 14. Review.

PMID:
23493335
10.

Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?

Ciccolini J, Gross E, Dahan L, Lacarelle B, Mercier C.

Clin Colorectal Cancer. 2010 Oct;9(4):224-8. doi: 10.3816/CCC.2010.n.033. Review.

PMID:
20920994
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk